Pharmacokinetic model for cefazolin distribution during total hip arthroplasty in dogs

American Journal of Veterinary Research

Volumn 57, Issue 5, 1996, Pages 720-723

  Marcellin Little, Denis J ^a   Papich, Mark G ^a   Richardson, Daniel C ^a,b   DeYoung, David J ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Hill's Pet Nutrition Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFAZOLIN;

ACETABULUM; ANIMAL; ANIMAL DISEASE; ARTICLE; ARTICULAR CARTILAGE; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; DOG; DOG DISEASE; DOSE RESPONSE; FEMUR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIP PROSTHESIS; INFECTION; METABOLISM; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TIME;

ACETABULUM; ANIMALS; ANTI-BACTERIAL AGENTS; CARTILAGE, ARTICULAR; CEFAZOLIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR; HIP DYSPLASIA, CANINE; HIP PROSTHESIS; MODELS, BIOLOGICAL; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS;

EID: 0030147275     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kaiser AB Antimicrobial prophylaxis in surgery N Engl J Med 1986;315.1129-1138
2. Hilt C, Flamant R, Mazas F, et al. Prophylactic cefazolin versus placebo in total hip replacement: report of a multicentre double-blind randomized trial. Lancet 1981;1:795-797.
3. Fitzgerald RH. Infections of hip prostheses and artificial joints, Infect Dis Clin North Am 1989;3.329-338.
4. Heath AF. Antimicrobial prophylaxis for arthroplasty and total joint replacement: discussion and review of published clinical trials Pharmacotherapy 1991;11:157-163
5. Burke JF The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961;50 161-168
6. Classen DC, Evans RS, Pestonik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgicalwound infection. N Eng J Med 1992;326:281-286.
7. Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatr 1986;108 835-840
8. Papich MG Clinical pharmacology of cephalosporin antibiotics J Am Vet Med Assoc 1984;184:344-347.
9. Fitzgerald RH, Thompson RL Cephalosporin antibiotics in the prevention and treatment of rnusculoskeletal sepsis. J Bone Joint Surg 1983,65-A:1201-1205
10. Rosin E, Uphoff TS, Schultz-Darken NJ, et al. Cefazolin antibacterial activity and concentrations in serum and the surgical wound in dogs. Am J Vet Res 1993;54 1317-1321.
11. Daly RC, Fitzgerald RH, Washington JA. Penetration of cefazolin into normal and osteomyehtic canine cortical bone. Antimicrob Agents Chemother 1982;22.461-469.
12. Wiggins CE, Nelson CL, Clarke R. et al. Concentration of antibiotics in normal bone after intravenous injection. J Bone Joint Surg 1978;60-A:93-96
13. Gustaferro GC, Steckelberg JM. Cephalosporin antimicrobial agents and related compounds. Mayo Clin Proc 1991,66:1064-1073.
14. Rosin E, Ebert S, Uphoff TS. et al. Penetration of antibiotics into the surgical wound in a canine model. Antimicrob Agents Chemother 1989;33:700-704.
15. Petersen SW, Rosin E. Cephalotin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs Vet Surg 1995; 24:347-351
16. Caprile KA The cephalosporin antimicrobial agents: a comprehensive review. J Vet Pharmacol Ther 1988,11:1-32.
17. Olmstead ML, Hohn RB, Turner TM Technique for canine total hip replacement Vet Surg 1981;10 44-50.
18. DeYoung DJ, DeYoung BA, Aberman HA, et al Implantation of an uncemented total hip prosthesis. Technique and initial results of 100 arthroplasties. Vet Surg 1992,21.168-177.
19. Vogelman B, Gudmundsson S, Leggett J, Ct al. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988,158:831-847
20. Craig WA, Ebert SC Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis 1991,74(Suppl):63-70.
21. Richardson DC, Aucoin DP, DeYoung DJ, et al. Pharma-cokinetic disposition of cefazolin in serum and tissue during canine total hip replacement. Vet Surg 1992,21 1-4
22. Tyczkowska K, Aucoin DP, Richardson DC, et al. Ionpaired liquid Chromatographic determination of cefazolin in canine serum and tissues. J Liquid Chromatogr 1987,10:2613-2624.
23. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed New York: Marcel Dekker Inc. 1982,1-494.
24. Hirsh DC, Smith TM. Osteomyelitis in the dog: microorganisms isolated and susceptibility to antimicrobial agents. J Small Anim Pract 1978,19:679-687.
25. Caywood DD, Wallace LJ, Braden TD Osteomyelitis in the dog: a review of 67 cases J Am Vet Med Assoc 1978;172.943-946.
26. Wilkens B, Sullivan P, McDonald TP, et al Effects of cephalothin, cefazolin and cefmetazole on the hemostatic mechanism in normal dogs, implications for the surgical patient. Vet Surg 1995; 24 25-31
27. Kunst MW, Mattie H. Cefazolin and cephredine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli J Infect Dis 1978,137.391-402